Cefalexin lysine
| Code | Size | Price |
|---|
| TAR-T25220-5mg | 5mg | £850.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Documents
Further Information
Bioactivity:
Cefalexin lysine is a derivative of Cefalexin which is an antibiotic.
CAS:
53950-14-4
Formula:
C22H31N5O6S
Molecular Weight:
493.58
Purity:
0.98
SMILES:
NCCCC[C@H](N)C(O)=O.[H][C@]12SCC(C)=C(N1C(=O)[C@H]2NC(=O)C(N)c1ccccc1)C(O)=O
References
1. Cad?rniga R, Barrios S, Segura J, Roberts DJ. Penetration of antibiotic into interstitial tissue fluid following parenteral administration of lysine cephalexin. Arzneimittelforschung. 1979;29(10):1547-9. PubMed PMID: 583220.
2. Barrios S, Sorensen JH, Spickett RG. Bioavailability of cephalexin after intramuscular injection of its lysine salt. J Pharm Pharmacol. 1975 Sep;27(9):711-2. PubMed PMID: 241820.
3. Kale SN, Jadhav AD, Verma S, Koppikar SJ, Kaul-Ghanekar R, Dhole SD, Ogale SB. Characterization of biocompatible NiCo2O4 nanoparticles for applications in hyperthermia and drug delivery. Nanomedicine. 2012 May;8(4):452-9. doi: 10.1016/j.nano.2011.07.010. Epub 2011 Aug 10. PubMed PMID: 21839056.
4. Nathan A, Zalipsky S, Ertel SI, Agathos SN, Yarmush ML, Kohn J. Copolymers of lysine and polyethylene glycol: a new family of functionalized drug carriers. Bioconjug Chem. 1993 Jan-Feb;4(1):54-62. Erratum in: Bioconjug Chem 1993 Sep-Oct;4(5):410. PubMed PMID: 8431513.